Monoclonal Antibody Diagnostic Reagent Market Scope And Analysis

  • Report Code : TIPRE00027682
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 168
Buy Now

Monoclonal Antibody Diagnostic Reagent Market Analysis and Scope (2022 to 2028)

Buy Now

Monoclonal Antibody Diagnostic Reagent Market Report Monoclonal Antibody Diagnostic Reagent Market Size and Share Monoclonal Antibody Diagnostic Reagent Market Scope and Analysis

Monoclonal Antibody Diagnostic Reagent Market Report Scope

Report Attribute Details
Market size in 2021 US$ 7.65 Billion
Market Size by 2028 US$ 18.51 Billion
Global CAGR (2021 - 2028) 13.5%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Tests
  • Enzyme Linked Immunosorbent
  • Double Antigen Sandwich Chemiluminescence Method
  • Recombinant Immunoblot Assay
  • Dot-immunogold Filtration Assay
By Application
  • Tumor Monitoring
  • Virus Detection
  • Hormones Diagnosis
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • BioGenex
  • Bio Rad Laboratories Inc
  • Biocare Medical LLC
  • Celltrion Healthcare Co Ltd
  • Creative Diagnostics
  • GenWay Biotech
  • Thermo Fisher Scientific Inc
  • ABclonal Inc
  • Apto Gen

    • Tests-Based Insights

    Based on tests, the global monoclonal antibody diagnostic reagent market is segmented into double antigen sandwich chemiluminescence method, enzyme linked immunosorbent assay, recombinant immunoblot assay, and dot-immunogold filtration assay. In 2021, the enzyme-linked immunosorbent assay segment accounted for the largest market share, and it is anticipated to register the highest CAGR from 2022 to 2028.

    Application-Based Insights

    Based on application, the global monoclonal antibody diagnostic reagent market is segmented into hormones diagnosis, tumor monitoring, virus detection, and other application. The tumor monitoring segment held the largest market share in 2021, and it is expected to register the highest CAGR during the forecast period.

    The global monoclonal antibody diagnostic reagent market players are adopting organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing product demand. A few of the key players operating in the market are BioGenex; Bio-Rad Laboratories, Inc.; Biocare Medical, LLC; Celltrion Healthcare Co., Ltd.; Creative Diagnostics; GenWay Biotech; Thermo Fisher Scientific Inc.; ABclonal, Inc.; Apto-Gen; and Abcam plc.